Actively Recruiting
Laser Treatment for Lichen Sclerosus
Led by Sciton · Updated on 2026-04-23
50
Participants Needed
1
Research Sites
199 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Fractional ablative laser treatment for Lichen Sclerosus lesion
CONDITIONS
Official Title
Laser Treatment for Lichen Sclerosus
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female aged 18 years or older
- Biopsy-proven vulvar lichen sclerosus lesion
- Experiencing one or more symptoms of lichen sclerosus such as dryness, itching, burning, bleeding, blistering, soreness, easy bruising, easy tearing, ulcerated lesions, or painful intercourse
- Negative urine pregnancy test if of childbearing potential before enrollment
- No vulvovaginal infection including fungi, bacterial vaginosis, or sexually transmitted infections
- Ability to understand and sign informed consent, questionnaires, and all investigation requirements
- Willing to consent to clinical photographs and ultrasound images of the treatment area
- Willing and able to follow the schedule of treatments and follow-up visits
You will not qualify if you...
- Pregnant, less than 3 months postpartum, or planning to become pregnant during the study
- Nursing mother
- History of uncontrolled malignant disease
- Active or chronic urogenital infection such as candida, herpes, herpes simplex, bacterial vaginosis, trichomoniasis, or other infections
- Immunocompromised conditions including lymphoma, AIDS, Wiskott-Aldrich syndrome
- Genital skin diseases like psoriasis due to risk of koebnerizing
- Use of immunosuppressants like mycophenolate, retinoids, azathioprine, or cyclosporin
- Known allergy or intolerance to local anesthesia
- History of connective tissue disease
- Known tendency for keloid formation
- Medical conditions that may affect wound healing
- Any other reason deemed by the investigator to prohibit participation in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Clinique Medicale Uro-Gyneco de l'Abitibi
Val-d'Or, Quebec, Canada, J9P1W1
Actively Recruiting
Research Team
J
J Patel
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here